CN109463562A - 一种仔鸡氨基酸生命素的配制方法 - Google Patents
一种仔鸡氨基酸生命素的配制方法 Download PDFInfo
- Publication number
- CN109463562A CN109463562A CN201811231956.7A CN201811231956A CN109463562A CN 109463562 A CN109463562 A CN 109463562A CN 201811231956 A CN201811231956 A CN 201811231956A CN 109463562 A CN109463562 A CN 109463562A
- Authority
- CN
- China
- Prior art keywords
- amino acid
- chick
- biogen
- phosphate
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 150000001413 amino acids Chemical class 0.000 title claims abstract description 18
- 238000002360 preparation method Methods 0.000 title claims abstract description 7
- 229940024606 amino acid Drugs 0.000 claims abstract description 17
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 claims abstract description 14
- MJVAVZPDRWSRRC-UHFFFAOYSA-N Menadione Chemical compound C1=CC=C2C(=O)C(C)=CC(=O)C2=C1 MJVAVZPDRWSRRC-UHFFFAOYSA-N 0.000 claims abstract description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 11
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 claims abstract description 7
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims abstract description 7
- 241000193422 Bacillus lentus Species 0.000 claims abstract description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 7
- 235000001287 Guettarda speciosa Nutrition 0.000 claims abstract description 7
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 claims abstract description 7
- 241000589540 Pseudomonas fluorescens Species 0.000 claims abstract description 7
- 241000270295 Serpentes Species 0.000 claims abstract description 7
- LSNNMFCWUKXFEE-UHFFFAOYSA-N Sulfurous acid Chemical compound OS(O)=O LSNNMFCWUKXFEE-UHFFFAOYSA-N 0.000 claims abstract description 7
- 239000004473 Threonine Substances 0.000 claims abstract description 7
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims abstract description 7
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims abstract description 7
- 235000006886 Zingiber officinale Nutrition 0.000 claims abstract description 7
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims abstract description 7
- 235000008397 ginger Nutrition 0.000 claims abstract description 7
- 125000005456 glyceride group Chemical group 0.000 claims abstract description 7
- 239000011656 manganese carbonate Substances 0.000 claims abstract description 7
- 229940093474 manganese carbonate Drugs 0.000 claims abstract description 7
- 235000006748 manganese carbonate Nutrition 0.000 claims abstract description 7
- 229910000016 manganese(II) carbonate Inorganic materials 0.000 claims abstract description 7
- XMWCXZJXESXBBY-UHFFFAOYSA-L manganese(ii) carbonate Chemical compound [Mn+2].[O-]C([O-])=O XMWCXZJXESXBBY-UHFFFAOYSA-L 0.000 claims abstract description 7
- 239000006041 probiotic Substances 0.000 claims abstract description 7
- 235000018291 probiotics Nutrition 0.000 claims abstract description 7
- 229960002898 threonine Drugs 0.000 claims abstract description 7
- 235000019155 vitamin A Nutrition 0.000 claims abstract description 7
- 239000011719 vitamin A Substances 0.000 claims abstract description 7
- 235000012711 vitamin K3 Nutrition 0.000 claims abstract description 7
- 239000011652 vitamin K3 Substances 0.000 claims abstract description 7
- 229940045997 vitamin a Drugs 0.000 claims abstract description 7
- 229940041603 vitamin k 3 Drugs 0.000 claims abstract description 7
- 239000011701 zinc Substances 0.000 claims abstract description 7
- 229910052725 zinc Inorganic materials 0.000 claims abstract description 7
- LSBIUXKNVUBKRI-UHFFFAOYSA-N 4,6-dimethylpyrimidine Chemical compound CC1=CC(C)=NC=N1 LSBIUXKNVUBKRI-UHFFFAOYSA-N 0.000 claims abstract description 6
- 229910019142 PO4 Inorganic materials 0.000 claims abstract description 6
- 241000191996 Pediococcus pentosaceus Species 0.000 claims abstract description 6
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 claims abstract description 6
- 239000000284 extract Substances 0.000 claims abstract description 6
- 239000010452 phosphate Substances 0.000 claims abstract description 6
- JZCPYUJPEARBJL-UHFFFAOYSA-N rimonabant Chemical compound CC=1C(C(=O)NN2CCCCC2)=NN(C=2C(=CC(Cl)=CC=2)Cl)C=1C1=CC=C(Cl)C=C1 JZCPYUJPEARBJL-UHFFFAOYSA-N 0.000 claims abstract description 6
- 229960003015 rimonabant Drugs 0.000 claims abstract description 6
- 244000061520 Angelica archangelica Species 0.000 claims abstract 2
- 244000273928 Zingiber officinale Species 0.000 claims abstract 2
- 238000011161 development Methods 0.000 abstract description 11
- 230000004584 weight gain Effects 0.000 abstract description 8
- 235000019786 weight gain Nutrition 0.000 abstract description 8
- 210000002303 tibia Anatomy 0.000 abstract description 5
- 230000004083 survival effect Effects 0.000 abstract description 2
- 210000000056 organ Anatomy 0.000 description 9
- 230000003115 biocidal effect Effects 0.000 description 8
- 238000000855 fermentation Methods 0.000 description 8
- 238000003756 stirring Methods 0.000 description 6
- 241000125175 Angelica Species 0.000 description 5
- 241000234314 Zingiber Species 0.000 description 5
- 241000711404 Avian avulavirus 1 Species 0.000 description 4
- 241000700605 Viruses Species 0.000 description 4
- 210000000988 bone and bone Anatomy 0.000 description 4
- 210000001669 bursa of fabricius Anatomy 0.000 description 4
- 230000036737 immune function Effects 0.000 description 4
- 208000015181 infectious disease Diseases 0.000 description 4
- 230000002458 infectious effect Effects 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 206010020751 Hypersensitivity Diseases 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- VTSWSQGDJQFXHB-UHFFFAOYSA-N 2,4,6-trichloro-5-methylpyrimidine Chemical compound CC1=C(Cl)N=C(Cl)N=C1Cl VTSWSQGDJQFXHB-UHFFFAOYSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241001478240 Coccus Species 0.000 description 1
- 235000019750 Crude protein Nutrition 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 208000031320 Teratogenesis Diseases 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 208000030961 allergic reaction Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 231100000315 carcinogenic Toxicity 0.000 description 1
- 231100000085 chronic toxic effect Toxicity 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- KCIDZIIHRGYJAE-YGFYJFDDSA-L dipotassium;[(2r,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] phosphate Chemical compound [K+].[K+].OC[C@H]1O[C@H](OP([O-])([O-])=O)[C@H](O)[C@@H](O)[C@H]1O KCIDZIIHRGYJAE-YGFYJFDDSA-L 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000010224 hepatic metabolism Effects 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 125000004435 hydrogen atom Chemical class [H]* 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000037353 metabolic pathway Effects 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 239000002366 mineral element Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 238000002703 mutagenesis Methods 0.000 description 1
- 231100000350 mutagenesis Toxicity 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 150000002972 pentoses Chemical class 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000007634 remodeling Methods 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
- A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
- A23K10/18—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/30—Animal feeding-stuffs from material of plant origin, e.g. roots, seeds or hay; from material of fungal origin, e.g. mushrooms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/111—Aromatic compounds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/116—Heterocyclic compounds
- A23K20/137—Heterocyclic compounds containing two hetero atoms, of which at least one is nitrogen
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/142—Amino acids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/142—Amino acids; Derivatives thereof
- A23K20/147—Polymeric derivatives, e.g. peptides or proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/158—Fatty acids; Fats; Products containing oils or fats
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/174—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/189—Enzymes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/20—Inorganic substances, e.g. oligoelements
- A23K20/26—Compounds containing phosphorus
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/20—Inorganic substances, e.g. oligoelements
- A23K20/30—Oligoelements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/70—Feeding-stuffs specially adapted for particular animals for birds
- A23K50/75—Feeding-stuffs specially adapted for particular animals for birds for poultry
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Polymers & Plastics (AREA)
- Engineering & Computer Science (AREA)
- Animal Husbandry (AREA)
- Zoology (AREA)
- Food Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Microbiology (AREA)
- Health & Medical Sciences (AREA)
- Birds (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Physiology (AREA)
- Inorganic Chemistry (AREA)
- Botany (AREA)
- Mycology (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
本发明涉及一种仔鸡氨基酸生命素的配制方法,其配方(按重量百分比)L‑苏氨酸2.2-3.2%、L‑抗坏血酸‑2‑磷酸酯2.3-3.3%、磷酸氢二钾2.5-3.5%、戊糖片球菌2.6-3.6%、二甲基嘧啶醇亚硫酸甲萘醌2-3%、迟缓芽孢杆菌2.1-3.1%、碳酸锰0.2-1.2%、蛇胆提取物0.9-1.9%、羌活1.2-2.2%、荧光假单胞菌1.5-2.5%、防风0.6-1.6%、麦芽糖酶0.9-1.9%、白芷1.9-2.9%、生姜1.8-2.8%、双甘油酯1.7-2.7%、维生素A 1.6-2.6%、蛋白锌1.5-2.5%、利莫那班1.3-2.3%、益生菌2.5-3.5%、氨基酸1.3-2.2%、水67.4-47.5%。本发明具有较好的调节仔鸡的生长发育,促增重、胫骨长度,提高成活率。
Description
技术领域
本发明属于仔鸡养殖技术领域,具体涉及利用天然生物与动、植物提取物,氨基酸、微生物菌、维生素、矿物元素为基本原料的仔鸡氨基酸生命素的配制方法。
背景技术
由于抗生素作为促生长剂使用所引起的病原菌耐药性和抗生素在动物体内及其产品中的残留问题,世界上取消饲用抗生素的呼声越来越高,事实上世界上不少国家已限制或禁止在饲料中使用抗生素,抗生素的代谢途径多种多样,但大多数以肝脏代谢为主,经胆汁由粪便排出体外,一些性质稳定的抗生素排泄到环境中后造成环境中的药物残留,这些残留的药物可通过畜禽产品直接蓄积于人体或通过环境释放蓄积到其它植物中,并最终以各种途径汇集于人体,导致人体的慢性毒性作用和体内正常菌群的耐药性变化,人体经常摄入低剂量的抗生素残留物,会逐渐在体内蓄积而导致各种器官发生病变,抗生素的残留对人体的影响主要表现在变态反应、过敏反应、免疫抑制、致畸、致癌、致突变等作用,氨基酸在仔鸡养殖中添加,能改善氨基酸的平衡程度,使饲料中氨基酸和蛋白质具有最高的营养价值,提高饲料蛋白质的消化利用率,可降低饲料中的粗蛋白含量2%以上,且不影响饲料效果,并能提高仔鸡的抗病和应激的能力。
发明内容
本发明的目的是根据上述不足之处,而研制一种富含氨基酸,能能调节仔鸡的生长发育,促增重、胫骨长度,能使新城疫病毒和传染性法氏囊病毒的抗体水平和免疫器官指数均达到最佳水平,促进免疫器官发育、增强其体液免疫功能,促进增重和骨骼的生长发育,提高成活率的仔鸡氨基酸生命素配制方法。
本发明的技术方案是这样实现,该产品是以L-苏氨酸、L-抗坏血酸-2-磷酸酯、磷酸氢二钾、戊糖片球菌、二甲基嘧啶醇亚硫酸甲萘醌、迟缓芽孢杆菌、碳酸锰 、蛇胆提取物、羌活 、荧光假单胞菌、防风、麦芽糖酶、白芷、生姜、双甘油酯、维生素A、蛋白锌、利莫那班、益生菌、氨基酸、水有机混合,科学配伍而成,其配制方法如下:
配方(按重量百分比)
L-苏氨酸2.2-3.2% L-抗坏血酸-2-磷酸酯2.3-3.3% 磷酸氢二钾2.5-3.5%
戊糖片球菌2.6-3.6% 二甲基嘧啶醇亚硫酸甲萘醌2-3% 迟缓芽孢杆菌2.1-3.1%
碳酸锰 0.2-1.2% 蛇胆提取物0.9-1.9% 羌活 1.2-2.2%
荧光假单胞菌1.5-2.5% 防风0.6-1.6% 麦芽糖酶0.9-1.9%
白芷1.9-2.9% 生姜 1.8-2.8% 双甘油酯 1.7-2.7%
维生素A 1.6-2.6% 蛋白锌 1.5-2.5% 利莫那班 1.3-2.3%
益生菌 2.5-3.5% 氨基酸1.3-2.2% 水67.4-47.5%
配制工艺:
该仔鸡氨基酸生命素是将上述产品按重量百分比配齐,混合制成,其步骤:采用能调节仔鸡的生长发育,促增重、胫骨长度的L-苏氨酸、L-抗坏血酸-2-磷酸酯、磷酸氢二钾、戊糖片球菌、二甲基嘧啶醇亚硫酸甲萘醌、迟缓芽孢杆菌,拌入第一个厌氧罐百分比三分之一的水中,均质搅拌29.6-30.6小时,恒温25-31°C,厌氧发酵34.8-35.8小时,能使新城疫病毒和传染性法氏囊病毒的抗体水平和免疫器官指数均达到最佳水平,再把碳酸锰 、蛇胆提取物、羌活 、荧光假单胞菌、防风、麦芽糖酶、白芷、生姜,拌入第二个厌氧罐百分比三分之一的水中,均质搅拌30.7-31.7小时,恒温25-29°C,厌氧发酵34.9-35.9小时,能促进免疫器官发育、增强其体液免疫功能,再把双甘油酯、维生素A、蛋白锌、利莫那班、益生菌、氨基酸,拌入第三个厌氧罐百分比三分之一水中,均质搅拌29-30小时,恒温24-30°C,厌氧发酵33-36小时,能促进增重和骨骼的生长发育,提高仔鸡成活率,然后再把三个厌氧罐中的液体混合在一个厌氧罐中,均质搅拌33-36小时,恒温18-26°C,厌氧发酵235-247小时,然后冷缺,包装。
有益效果:
能调节仔鸡的生长发育,促增重、胫骨长度,能使新城疫病毒和传染性法氏囊病毒的抗体水平和免疫器官指数均达到最佳水平,促进免疫器官发育、增强其体液免疫功能,促进增重和骨骼的生长发育,提高仔鸡成活率。
具体实施方式:
本发明的仔鸡氨基酸生命素主要由下述重量百分比原料组成,其步骤:L-苏氨酸2.2-3.2%、L-抗坏血酸-2-磷酸酯2.3-3.3%、磷酸氢二钾2.5-3.5%、戊糖片球菌2.6-3.6%、二甲基嘧啶醇亚硫酸甲萘醌2-3%、迟缓芽孢杆菌2.1-3.1%、碳酸锰 0.2-1.2%、蛇胆提取物0.9-1.9%、羌活 1.2-2.2%、荧光假单胞菌1.5-2.5%、防风0.6-1.6%、麦芽糖酶0.9-1.9%、白芷1.9-2.9%、生姜 1.8-2.8%、双甘油酯 1.7-2.7%、维生素A 1.6-2.6%、蛋白锌1.5-2.5%、利莫那班 1.3-2.3%、益生菌 2.5-3.5%、氨基酸1.3-2.2%、水67.4-47.5%,混合制成,采用能调节仔鸡的生长发育,促增重、胫骨长度的L-苏氨酸、L-抗坏血酸-2-磷酸酯、磷酸氢二钾、戊糖片球菌、二甲基嘧啶醇亚硫酸甲萘醌、迟缓芽孢杆菌,拌入第一个厌氧罐百分比三分之一的水中,均质搅拌29.6-30.6小时,恒温25-31°C,厌氧发酵34.8-35.8小时,能使新城疫病毒和传染性法氏囊病毒的抗体水平和免疫器官指数均达到最佳水平,再把碳酸锰 、蛇胆提取物、羌活 、荧光假单胞菌、防风、麦芽糖酶、白芷、生姜,拌入第二个厌氧罐百分比三分之一的水中,均质搅拌30.7-31.7小时,恒温25-29°C,厌氧发酵34.9-35.9小时,能促进免疫器官发育、增强其体液免疫功能,再把双甘油酯、维生素A、蛋白锌、利莫那班、益生菌、氨基酸,拌入第三个厌氧罐百分比三分之一水中,均质搅拌29-30小时,恒温24-30°C,厌氧发酵33-36小时,能促进增重和骨骼的生长发育,提高仔鸡成活率,然后再把三个厌氧罐中的液体混合在一个厌氧罐中,均质搅拌33-36小时,恒温18-26°C,厌氧发酵235-247小时,然后冷缺,包装。
以上所述,仅是本发明的较佳实施例而已,并非是对本发明作其它形式的限制,任何熟悉本专业的技术人员可能利用上述揭示的技术内容加以变更或改型为等同变化的等效实施例。但是凡是未脱离本发明技术方案内容,依据本发明的技术实质对以上实施例所作的任何简单修改、等同变化与改型,仍属于本发明技术方案的保护范围。
Claims (1)
1.一种仔鸡氨基酸生命素的配制方法,其配方(按重量百分比)
L-苏氨酸2.2-3.2% L-抗坏血酸-2-磷酸酯2.3-3.3% 磷酸氢二钾2.5-3.5%
戊糖片球菌2.6-3.6% 二甲基嘧啶醇亚硫酸甲萘醌2-3% 迟缓芽孢杆菌2.1-3.1%
碳酸锰 0.2-1.2% 蛇胆提取物0.9-1.9% 羌活 1.2-2.2%
荧光假单胞菌1.5-2.5% 防风0.6-1.6% 麦芽糖酶0.9-1.9%
白芷1.9-2.9% 生姜 1.8-2.8% 双甘油酯 1.7-2.7%
维生素A 1.6-2.6% 蛋白锌 1.5-2.5% 利莫那班 1.3-2.3%
益生菌 2.5-3.5% 氨基酸1.3-2.2% 水67.4-47.5%。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811231956.7A CN109463562A (zh) | 2018-10-22 | 2018-10-22 | 一种仔鸡氨基酸生命素的配制方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811231956.7A CN109463562A (zh) | 2018-10-22 | 2018-10-22 | 一种仔鸡氨基酸生命素的配制方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN109463562A true CN109463562A (zh) | 2019-03-15 |
Family
ID=65664030
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201811231956.7A Withdrawn CN109463562A (zh) | 2018-10-22 | 2018-10-22 | 一种仔鸡氨基酸生命素的配制方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN109463562A (zh) |
-
2018
- 2018-10-22 CN CN201811231956.7A patent/CN109463562A/zh not_active Withdrawn
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103332971B (zh) | 一种柠檬酵素液态肥料及其制备方法 | |
CN102775207A (zh) | 一种鸡粪猪粪混合发酵肥料及其制备方法 | |
CN107445769A (zh) | 一种茶叶生态专用肥 | |
CN102210388B (zh) | 用提取黄酮后的荞麦花叶废弃物制备饲料添加剂的方法 | |
CN101856062A (zh) | 一种虫草基饲用免疫增强剂及其生产方法 | |
CN104585506A (zh) | 一株植物乳杆菌p-8的用途 | |
CN101669580A (zh) | 一种用浒苔发酵制备饲料添加剂的方法 | |
CN105815550B (zh) | 一株可降低大规模肉鸡养殖中粪臭素、吲哚释放的植物乳杆菌及其应用 | |
CN101139554B (zh) | 中草药酵母硒的固态发酵制备方法 | |
CN104855692B (zh) | 一种桡足类室内大规模、高密度养殖饵料 | |
CN103478441A (zh) | 一种大米活性菌肽鱼饲料及其应用 | |
CN104605138A (zh) | 一种含发酵红豆杉的家禽饲料添加剂及其制备方法和应用 | |
CN103947825B (zh) | 一种宠物饲料添加剂及其生产方法 | |
CN103392933B (zh) | 一种刺参幼参全平衡超微颗粒饲料 | |
CN106359849A (zh) | 一种含腐植酸螯合微量元素的发酵饲料及其制备方法 | |
CN109463562A (zh) | 一种仔鸡氨基酸生命素的配制方法 | |
CN109170148A (zh) | 一种无抗氨基酸仔猪混合饲料添加剂的配制方法 | |
CN105995093A (zh) | 一种种猪用微生物发酵饲料及其制备方法 | |
CN116584577A (zh) | 一种含活体益生菌的后生元及其制备方法和用途 | |
CN107445700A (zh) | 一种小麦生态专用肥 | |
CN103519004B (zh) | 一种抗虫杀菌复合多元饲料及其制造方法 | |
Li et al. | Effects of probiotic fermented kitchen waste on the growth and propagation of rotifer Brachionus calyciflorus | |
CN105831489A (zh) | 一种提高鳜鱼抗应激性的饲料及其制备方法 | |
CN104799016A (zh) | 一种生物复合酶及其制备方法 | |
CN109874939A (zh) | 一种抗菌蝇蛆蛋白及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
WW01 | Invention patent application withdrawn after publication |
Application publication date: 20190315 |
|
WW01 | Invention patent application withdrawn after publication |